Search

Search Constraints

You searched for: Author/Creator Meijer, Sybren L

Search Results

1. A phase Ib/II study of regorafenib and paclitaxel in patients with beyond first-line advanced esophagogastric carcinoma (REPEAT). (June 2022)

2. Barrett's oesophagus patients with low-grade dysplasia can be accurately risk-stratified after histological review by an expert pathology panel. Issue 5 (17th July 2014)

3. Derivation of genetic biomarkers for cancer risk stratification in Barrett's oesophagus: a prospective cohort study. Issue 10 (23rd June 2015)

4. Evolution of oesophageal adenocarcinoma from metaplastic columnar epithelium without goblet cells in Barrett's oesophagus. Issue 6 (23rd December 2015)

5. HER2 gene amplification in patients with breast cancer with equivocal IHC results. Issue 12 (11th August 2011)

6. Histopathologist features predictive of diagnostic concordance at expert level among a large international sample of pathologists diagnosing Barrett's dysplasia using digital pathology. Issue 5 (18th December 2019)

7. Improved diagnostic stratification of digitised Barrett's oesophagus biopsies by p53 immunohistochemical staining. Issue 6 (28th February 2018)

8. The combination of autofluorescence endoscopy and molecular biomarkers is a novel diagnostic tool for dysplasia in Barrett's oesophagus. Issue 1 (10th April 2014)

9. Tumor‐immune landscape patterns before and after chemoradiation in resectable esophageal adenocarcinomas. Issue 3 (10th December 2021)